# Reneo Pharmaceuticals Inc. (RPHM)

Source: https://www.quantisnow.com/company/RPHM
Generated: 2026-11-15T17:04:18.794Z

- Ticker: RPHM
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- Website: reneopharma.com

## About

Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. The company was incorporated in 2014 and is headquartered in San Diego, California.

## Latest RPHM news and filings

- 2024-10-08 23:34 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-reneo-pharmaceuticals-inc-5720213)
- 2024-10-08 23:29 UTC [SEC Form 4] [President and CEO Saccomano Nicholas A was granted 4,556 shares (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-saccomano-nicholas-a-was-granted-4556-shares-5720212)
- 2024-10-08 23:28 UTC [SEC Form 4] [SEC Form 4 filed by Director Phillips Andrew John](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-phillips-andrew-john-5720211)
- 2024-10-08 23:27 UTC [SEC Form 4] [SEC Form 4 filed by Director Mathers Edward T](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-mathers-edward-t-5720210)
- 2024-10-08 23:27 UTC [SEC Form 4] [SEC Form 4 filed by Director Manke Isaac](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-manke-isaac-5720209)
- 2024-10-08 23:26 UTC [SEC Form 4] [Chief Financial Officer Leverone Jason A. was granted 16,331 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-leverone-jason-a-was-granted-16331-shares-5720208)
- 2024-10-08 23:25 UTC [SEC Form 4] [SEC Form 4 filed by Director Jansen Valerie Malyvanh](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-jansen-valerie-malyvanh-5720207)
- 2024-10-08 23:24 UTC [SEC Form 4] [SEC Form 4 filed by Chief Scientific Officer Hartley Dylan](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-scientific-officer-hartley-dylan-5720205)
- 2024-10-08 23:23 UTC [SEC Form 4] [SEC Form 4 filed by Director Grey Michael G](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-grey-michael-g-5720204)
- 2024-10-08 23:21 UTC [SEC Form 4] [Director Carruthers R Michael was granted 4,939 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-carruthers-r-michael-was-granted-4939-shares-sec-form-5720202)
- 2024-10-08 23:20 UTC [SEC Form 4] [SEC Form 4 filed by Chief Medical Officer Agresta Samuel](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-medical-officer-agresta-samuel-5720201)
- 2024-10-08 23:14 UTC [SEC Form 3] [SEC Form 3 filed by new insider Saccomano Nicholas A](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-saccomano-nicholas-a-5720198)
- 2024-10-08 23:12 UTC [SEC Form 3] [SEC Form 3 filed by new insider Phillips Andrew John](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-phillips-andrew-john-5720195)
- 2024-10-08 23:11 UTC [SEC Form 3] [SEC Form 3 filed by new insider Manke Isaac](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-manke-isaac-5720188)
- 2024-10-08 23:10 UTC [SEC Form 3] [SEC Form 3 filed by new insider Leverone Jason A.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-leverone-jason-a-5720184)
- 2024-10-08 23:09 UTC [SEC Form 3] [SEC Form 3 filed by new insider Jansen Valerie Malyvanh](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-jansen-valerie-malyvanh-5720181)
- 2024-10-08 23:09 UTC [SEC Form 3] [SEC Form 3 filed by new insider Hartley Dylan](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-hartley-dylan-5720180)
- 2024-10-08 23:07 UTC [SEC Form 3] [SEC Form 3 filed by new insider Carruthers R Michael](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-carruthers-r-michael-5720179)
- 2024-10-08 23:06 UTC [SEC Form 3] [SEC Form 3 filed by new insider Agresta Samuel](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-agresta-samuel-5720177)
- 2024-10-08 21:26 UTC [SEC Form 8-K] [Reneo Pharmaceuticals Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Regulation FD Disclosure](https://www.quantisnow.com/insight/reneo-pharmaceuticals-inc-filed-sec-form-8-k-unregistered-sales-of-5720093)
- 2024-10-04 20:57 UTC [Public Offering] [OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million](https://www.quantisnow.com/insight/onkure-announces-closing-of-merger-with-reneo-pharmaceuticals-and-concurrent-5717315)
- 2024-10-03 00:20 UTC [Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure](https://www.quantisnow.com/insight/reneo-pharmaceuticals-announces-stockholder-approval-of-merger-with-onkure-5714038)
- 2024-10-02 21:23 UTC [SEC Form 425] [SEC Form 425 filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reneo-pharmaceuticals-inc-5713564)
- 2024-10-02 21:20 UTC [SEC Form 8-K] [SEC Form 8-K filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-reneo-pharmaceuticals-inc-5713550)
- 2024-09-26 20:00 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-reneo-pharmaceuticals-inc-5705864)
- 2024-09-26 13:33 UTC [Insider Buy] [Large owner Leonard Braden Michael bought $144,738 worth of shares (98,346 units at $1.47) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-leonard-braden-michael-bought-144738-worth-of-shares-5705614)
- 2024-09-20 11:04 UTC [SEC Form 425] [SEC Form 425 filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reneo-pharmaceuticals-inc-5700313)
- 2024-09-20 11:00 UTC [SEC Form 8-K] [SEC Form 8-K filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-reneo-pharmaceuticals-inc-5700312)
- 2024-09-19 15:02 UTC [Insider Buy] [Large owner Leonard Braden Michael bought $76,237 worth of shares (56,106 units at $1.36) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-leonard-braden-michael-bought-76237-worth-of-shares-5699371)
- 2024-09-16 20:15 UTC [Insider Buy] [Large owner Leonard Braden Michael bought $484,344 worth of shares (358,923 units at $1.35) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-leonard-braden-michael-bought-484344-worth-of-shares-5695077)
- 2024-09-13 20:21 UTC [SEC Form 8-K] [SEC Form 8-K filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-reneo-pharmaceuticals-inc-5693492)
- 2024-08-27 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-reneo-pharmaceuticals-inc-5672533)
- 2024-08-26 21:06 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-reneo-pharmaceuticals-inc-5672196)
- 2024-08-26 10:10 UTC [SEC Form S-4] [Amendment: SEC Form S-4/A filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-4a-filed-by-reneo-pharmaceuticals-inc-5671201)
- 2024-08-19 10:06 UTC [SEC Form S-4] [Amendment: SEC Form S-4/A filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-4a-filed-by-reneo-pharmaceuticals-inc-5663590)
- 2024-08-15 00:48 UTC [Insider Buy] [Large owner Leonard Braden Michael bought $380,598 worth of shares (271,826 units at $1.40) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-leonard-braden-michael-bought-380598-worth-of-shares-5660293)
- 2024-08-13 21:03 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-reneo-pharmaceuticals-inc-5657475)
- 2024-08-13 20:03 UTC [SEC Form 425] [SEC Form 425 filed by Reneo Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reneo-pharmaceuticals-inc-5656680)
- 2024-08-13 20:00 UTC [SEC Form 8-K] [Reneo Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/reneo-pharmaceuticals-inc-filed-sec-form-8-k-results-of-operations-5656610)
- 2024-08-13 11:35 UTC [Public Offering] [Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results](https://www.quantisnow.com/insight/reneo-pharmaceuticals-reports-second-quarter-2024-financial-results-5655996)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/RPHM
- Earnings history: https://www.quantisnow.com/earnings/RPHM
- Dividend history: https://www.quantisnow.com/dividends/RPHM
- Insider transactions: https://www.quantisnow.com/insiders/RPHM
- Options chain: https://www.quantisnow.com/options/RPHM
- SEC 8-K filings only: https://www.quantisnow.com/company/RPHM/8-k
- RSS and alerts for RPHM: https://www.quantisnow.com/docs/rss-feeds.md